Democratic hopefuls take aim at insurer and pharma profits

WASHINGTON — Sen. Bernie Sanders and other progressives seeking the Democratic presidential nomination are zeroing in on pharmaceutical and insurer profits, money they say would be better spent providing health care for everyone under “Medicare for All.”

Their idea: Health care dollars from government programs, employers and families that are going into the pockets of investors instead could be used to pay for services. If people want a health care system that will not bankrupt them, “the answer is to get rid of the profiteering of the drug companies and the insurance companies (and) move to Medicare for All,” Sanders said during the recent Democratic debates.

But research by The Associated Press suggests those dollars might not go so far. While there’s no single ledger for drugmakers and insurers, the AP found major companies had about $97 billion in profits last year. That wouldn’t even cover a couple of weeks in a health care system that costs $3.6 trillion a year.

“My view is that we are having a debate in fantasy world,” said Marc Goldwein, senior policy director with the nonpartisan Committee for a Responsible Federal Budget. “Insurer profits and excess drug costs are large in dollar terms but small relative to the size of national health expenditures.”

To be sure, Sanders and other Medicare for All advocates also acknowledge the need to raise taxes to pay for the plan. It would offer comprehensive medical care to every U.S. resident with no premiums or deductibles, and virtually no copays.

But Sanders’ legislation does not specify new revenues . Instead, the Vermont independent provides a separate list of “options” that include higher taxes on the wealthy, corporations and employers while promising the middle class will be better off.

In a statement, Sanders’ office said he believes that “guaranteeing health care for all Americans as a right requires ending the profit motive of the insurance industry.”

It added that Sanders “sees a role for pharmaceutical innovation, but opposes a rigged system that allows corporations to use their monopoly power to charge Americans … more for the exact same lifesaving drugs that can be purchased in Canada, the UK, France, Japan, and Germany.”

During the last round of Democratic debates, Sens. Elizabeth Warren of Massachusetts and Kamala Harris of California joined Sanders in training rhetorical fire on drugmakers and insurers. They had their own profit estimates.

“Insurance companies do not have a God-given right to make $23 billion in profits and suck it out of our health care system,” Warren said.

“Let’s talk about math,” Harris said. “Let’s talk about the fact that the pharmaceutical companies and the insurance companies last year alone profited $72 billion, and that is on the backs of American families.”

For its estimate, the AP reviewed the financial statements of the eight for-profit, publicly traded health insurers in the U.S. and found they made around $26 billion total last year. Their profit margins averaged a little more than 4%. The list included UnitedHealth, Anthem and Humana.

Some major insurers outside this group are non-profit and plow their earnings back.

A spokeswoman for America’s Health Insurance Plans, the main insurer trade group, said the vast majority of premiums go to health care. The group’s website cites an estimate that about 80 cents of every premium dollar goes for medical care, and only about 2 cents goes to profit. Other expenses included administration and taxes.

For drugmakers, the AP asked FactSet, a global financial data firm, to run the numbers for major pharmaceutical and biotechnology companies. FactSet focused on 19 companies that are part of the Standard & Poor’s 500 stock index. Its analysis found they made $71 billion on revenues of $385.5 billion last year, with an average profit margin of 18%. The list included Johnson & Johnson, Merck, Gilead, Amgen and Pfizer.

The Pharmaceutical Research and Manufacturers of America said such calculations are too simplistic and don’t convey the full picture.

Harvard University health care economist Amitabh Chandra said focusing on the profitability of major drugmakers misses a crucial part of the drug industry’s story. Many companies engaged in research and drug development don’t make money and are instead kept afloat by investors hoping for discoveries that will lead to big returns.

“It’s incomplete — it’s not the universe of all companies,” Chandra said. “It’s sort of like saying lottery winners are rich.”

He cautioned against health care remakes that just try to squeeze the profits.

“There have been some proposals that put 100% tax on pharma profits. That’s the equivalent of putting up a giant billboard that says ‘Don’t Make Drugs.’”

But Medicare for All proponents have found a simple, appealing argument for their proposal, said Tara O’Neill Hayes, a health policy expert with the American Action Forum, a centre-right think-tank . It skips over the complexities of a plan that would put 18% of the economy under government control.

“It is really easy, and it sells with the general public,” Hayes said. “People like to have an enemy, and they like to point to someone as the problem. We’ve known that for decades.”

Just Posted

Ad firm says controversial billboards promoting Bernier’s party staying up

OTTAWA — The owner of billboards currently showcasing ads that seek to… Continue reading

14 year old and family need community support after teen hit by car

A 14 year old and his family need financial help after the… Continue reading

Police say someone fired paintballs at people outside drug consumption site in Lethbridge

LETHBRIDGE, Alta. — Police in southern Alberta are investigating after they say… Continue reading

Is federal carbon tax killing jobs? Experts say answer isn’t ‘black and white’

REGINA — The Saskatchewan government says the federal carbon tax is killing… Continue reading

New book assesses Trudeau government’s record of living up to pledges

OTTAWA — A new book arriving on the eve of the federal… Continue reading

WATCH: Snakes, lizards and more at the Western Canadian Reptile Expo in Red Deer

The 10th annual Western Canadian Reptile Expo is this weekend in Red… Continue reading

Your community calendar

Tuesday and Sept. 3 The Tony Connelly Singers provide an opportunity to… Continue reading

A look at policy areas scrutinized by a new book on the Trudeau government

OTTAWA — A group of two dozen Canadian academics took a deep… Continue reading

Father of suspected B.C. killer seeks access to video taken before son’s death

VANCOUVER — The father of a suspected killer of three people in… Continue reading

US tech industry becomes hotbed for employee activism

SAN FRANCISCO — When Liz O’Sullivan was hired at the New York… Continue reading

Jolie shares pride in son Maddox, joining Marvel movie

ANAHEIM, Calif. — Angelina Jolie says she’s “so proud” that her 18-year-old… Continue reading

Extinction bites: countries agree to protect sharks and rays

GENEVA — Countries have agreed to protect more than a dozen shark… Continue reading

Trudeau and Trump hold face to face meeting on sidelines of G7 summit

BIARRITZ, France — Justin Trudeau met face-to-face with U.S. President Donald Trump… Continue reading

Study reveals new details of overseas Cold War intelligence effort by Canadians

OTTAWA — Canada enlisted citizens who travelled to Communist countries during the… Continue reading

Most Read